Global Health delivered exceptional fourth-quarter results for the quarter ended March 2026, with net profit surging 42% to ₹143.99 crore compared to ₹101.40 crore in the corresponding quarter of the previous year. According to reports from Business Standard, the company's sales revenue grew 24.46% to ₹1,159.05 crore during the quarter, up from ₹931.25 crore in Q4 FY2025. The strong performance demonstrates the company's robust operational efficiency and market positioning.
The company's Mobile and EMS segment posted revenue growth of 4% year-on-year, with weaker mobile revenues offset by higher IT hardware and components contribution, as reported by Financial Express. The segment's EBIT margin stood at 3.6%, indicating stable operational performance despite mixed revenue dynamics. This segment-wise breakdown provides insights into the company's diversified business portfolio and its ability to maintain profitability across different product categories.
For the complete financial year ended March 2026, Global Health maintained its growth momentum with net profit rising 15.58% to ₹556.46 crore compared to ₹481.44 crore in the previous year. As reported by Business Standard, the company's annual sales increased 19.44% to ₹4,410.27 crore in FY2026, compared to ₹3,692.35 crore in FY2025. The sustained growth across both quarterly and annual periods indicates consistent business expansion and market penetration strategies.
The company's operating profit margin (OPM) improved to 21.03% in Q4 FY2026 from 20.84% in the corresponding quarter of the previous year, according to Business Standard data. For the full year, the OPM stood at 23.76% compared to 20.84% in FY2025. This improvement in operational efficiency, combined with strong revenue growth, contributed significantly to the company's enhanced profitability metrics across both quarterly and annual periods.
